QualityStocksNewsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) to Host Investor Webinar Highlighting Cancer Immunotherapy Pipeline
Calidi Biotherapeutics (NYSE American: CLDI) will host a live investor webinar on April 24, 2025, at 4:15 p.m. ET, featuring its new Chief Medical Officer, Dr. Guy Travis Clifton. The event will spotlight Calidi’s stem cell-based delivery platforms for oncolytic virus therapies, including the FDA-cleared CLD-201, which is advancing toward trials for solid tumors. Additional program updates will include CLD-400 for metastatic and lung cancer and CLD-101 for high-grade gliomas. A live Q&A will follow the presentation. To view the full press release, visit: https://ibn.fm/WPzHW About Calidi Biotherapeutics Calidi Biotherapeutics specializes in proprietary technology that empowers the immune system to…